9 December 2021 | 9:00-9:55 CET
We all share the same objective: Ensuring that patients get the medicines and vaccines they need in a timely way.
The COVID-19 pandemic has tested Europe’s medicine supply chains like never before. It has affected manufacturing, trade and logistics. Matching the supply of medicines to fluctuating demand can be a challenge at the best of times. So, what have we learned?
- What does Europe need in order to avoid shortages?
- How can we ensure collaboration all along the supply chains to overcome supply challenges?
- What constitutes strong supply chains?
- Does security of supply stem from a broader commitment to innovation and competitiveness?
Radu Costin Ganescu, President of the national Coalition of organisations for patients with chronic conditions of Romania (COPAC), and Vice President of the EPF Board
Domenico Di Giorgio, Head of Inspection & Certification Department, AIFA - Italian Medicines Agency
Marco Farinelli, Supply chain manager (MCAM), AstraZeneca, and Chair of the Supply Chain working group, EFPIA
Sylvain Giraud, Head of Unit, Medical products: quality, safety, innovation, DG SANTE
Dolors Montserrat, Head of the EPP Spanish Delegation, Member of the European Parliament